CS
PLXP

Credit Suisse’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Credit Suisse’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-27,394
Closed -$151K – 4649
2020
Q4 		$151K Buy
+27,394
New +$121K ﹤0.01% 4142

Other funds holding PLXP

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse's PLXP Position: Q1 2021 in Review

Credit Suisse sold out of PLx Pharma Inc. Common Stock (PLXP) in Q1 2021, closing a stake of 27,394 shares — an estimated $151K sold.

Credit Suisse first reported a position in PLXP in Q4 2020 and held it in 1 quarter. The position peaked at $151K in Q4 2020. 37 funds tracked by Wall St. Rank hold PLXP as of Q1 2021.

  • Credit Suisse reported no remaining PLx Pharma Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Credit Suisse sold 27,394 PLx Pharma Inc. Common Stock shares in Q1 2021, an estimated $151K.
  • Credit Suisse first reported a position in PLx Pharma Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Credit Suisse's PLx Pharma Inc. Common Stock position peaked at $151K in Q4 2020.
  • 37 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q1 2021.

Based on Credit Suisse's 13F filing for Q1 2021, filed 14 May 2021.